Status: Recruiting
Skeletal Muscle-derived Cell Implantation for Treatment of Fecal Incontinence
The objective of this study is the final assessment of clinical safety and efficacy of autologous autologous skeletal muscle derived cells for patients with urge fecal incontinence due to external anal sphincter dysfunction caused by its disruption and/or weakness.
Participants needed: 290
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Innovacell GmbHUpdated: Mar 12, 2025Locations: 31
Eligibility criteria
Patients must be at least 18 years old [+6]
Patients for whom the investigator determines that FI has a different cause than... [+18]